24-hour IOP-lowering Effect of 0.01% Bimatoprost

Completed · Phase 4

Conditions studied: Intraocular Pressure, Glaucoma, Ocular Hypertension

In brief

This study will evaluate the 24-hour IOP-lowering efficacy of 0.01% bimatoprost once daily in patients with glaucoma or ocular hypertension

Key facts

Study ID

NCT01271686

Run by

University of California, San Diego

People needed

16

Starts

2011-01-01

Expected to finish

2012-10-01

Last updated by the study team

2014-06-19

Who can join

Age: 40 and older, up to 80. Sex: any. Healthy volunteers: not accepted.

You may qualify if…

• primary open-angle glaucoma or ocular hypertension

You may not qualify if…

• Women of childbearing potential previous glaucoma surgery presence of other eye disease

Where it is running

• UCSD Shiley Eye Center — La Jolla, California, United States

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.